Olfactory neuronal cells as a promising tool to realize the "druggable genome" approach for drug discovery in neuropsychiatric disorders

"Druggable genome" is a novel concept that emphasizes the importance of using the information of genome-wide genetic studies for drug discovery and development. Successful precedents of "druggable genome" have recently emerged for some disorders by combining genomic and gene expr...

Full description

Saved in:
Bibliographic Details
Main Authors: Mihaljevic, Marina, Lam, Max, Ayala-Grosso, Carlos, Davis-Batt, Finn, Schretlen, David J., Ishizuka, Koko, Yang, Kun, Sawa, Akira
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Article
Language:English
Published: 2023
Subjects:
Online Access:https://hdl.handle.net/10356/169592
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-169592
record_format dspace
spelling sg-ntu-dr.10356-1695922023-07-30T15:38:12Z Olfactory neuronal cells as a promising tool to realize the "druggable genome" approach for drug discovery in neuropsychiatric disorders Mihaljevic, Marina Lam, Max Ayala-Grosso, Carlos Davis-Batt, Finn Schretlen, David J. Ishizuka, Koko Yang, Kun Sawa, Akira Lee Kong Chian School of Medicine (LKCMedicine) Institute of Mental Health Science::Medicine Olfactory Neuronal Cells Cognition "Druggable genome" is a novel concept that emphasizes the importance of using the information of genome-wide genetic studies for drug discovery and development. Successful precedents of "druggable genome" have recently emerged for some disorders by combining genomic and gene expression profiles with medical and pharmacological knowledge. One of the key premises for the success is the good access to disease-relevant tissues from "living" patients in which we may observe molecular expression changes in association with symptomatic alteration. Thus, given brain biopsies are ethically and practically difficult, the application of the "druggable genome" approach is challenging for neuropsychiatric disorders. Here, to fill this gap, we propose the use of olfactory neuronal cells (ONCs) biopsied and established via nasal biopsy from living subjects. By using candidate genes that were proposed in a study in which genetic information, postmortem brain expression profiles, and pharmacological knowledge were considered for cognition in the general population, we addressed the utility of ONCs in the "druggable genome" approach by using the clinical and cell resources of an established psychosis cohort in our group. Through this pilot effort, we underscored the chloride voltage-gated channel 2 (CLCN2) gene as a possible druggable candidate for early-stage psychosis. The CLCN2 gene expression was associated with verbal memory, but not with other dimensions in cognition, nor psychiatric manifestations (positive and negative symptoms). The association between this candidate molecule and verbal memory was also confirmed at the protein level. By using ONCs from living subjects, we now provide more specific information regarding molecular expression and clinical phenotypes. The use of ONCs also provides the opportunity of validating the relationship not only at the RNA level but also protein level, leading to the potential of functional assays in the future. Taken together, we now provide evidence that supports the utility of ONCs as a tool for the "druggable genome" approach in translational psychiatry. Published version This study was supported by NIH grants MH-092443, MH-094268, MH-105660, and MH-107730; foundation grants from Stanley and RUSK/S-R (to AS), an award from Brain and Behavior Research Foundation (to KY), and a Fulbright fellowship (to MM). 2023-07-25T06:32:18Z 2023-07-25T06:32:18Z 2023 Journal Article Mihaljevic, M., Lam, M., Ayala-Grosso, C., Davis-Batt, F., Schretlen, D. J., Ishizuka, K., Yang, K. & Sawa, A. (2023). Olfactory neuronal cells as a promising tool to realize the "druggable genome" approach for drug discovery in neuropsychiatric disorders. Frontiers in Neuroscience, 16, 1081124-. https://dx.doi.org/10.3389/fnins.2022.1081124 1662-4548 https://hdl.handle.net/10356/169592 10.3389/fnins.2022.1081124 36967982 2-s2.0-85150754161 16 1081124 en Frontiers in Neuroscience © 2023 Mihaljevic, Lam, Ayala-Grosso, Davis-Batt, Schretlen, Ishizuka, Yang and Sawa. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Science::Medicine
Olfactory Neuronal Cells
Cognition
spellingShingle Science::Medicine
Olfactory Neuronal Cells
Cognition
Mihaljevic, Marina
Lam, Max
Ayala-Grosso, Carlos
Davis-Batt, Finn
Schretlen, David J.
Ishizuka, Koko
Yang, Kun
Sawa, Akira
Olfactory neuronal cells as a promising tool to realize the "druggable genome" approach for drug discovery in neuropsychiatric disorders
description "Druggable genome" is a novel concept that emphasizes the importance of using the information of genome-wide genetic studies for drug discovery and development. Successful precedents of "druggable genome" have recently emerged for some disorders by combining genomic and gene expression profiles with medical and pharmacological knowledge. One of the key premises for the success is the good access to disease-relevant tissues from "living" patients in which we may observe molecular expression changes in association with symptomatic alteration. Thus, given brain biopsies are ethically and practically difficult, the application of the "druggable genome" approach is challenging for neuropsychiatric disorders. Here, to fill this gap, we propose the use of olfactory neuronal cells (ONCs) biopsied and established via nasal biopsy from living subjects. By using candidate genes that were proposed in a study in which genetic information, postmortem brain expression profiles, and pharmacological knowledge were considered for cognition in the general population, we addressed the utility of ONCs in the "druggable genome" approach by using the clinical and cell resources of an established psychosis cohort in our group. Through this pilot effort, we underscored the chloride voltage-gated channel 2 (CLCN2) gene as a possible druggable candidate for early-stage psychosis. The CLCN2 gene expression was associated with verbal memory, but not with other dimensions in cognition, nor psychiatric manifestations (positive and negative symptoms). The association between this candidate molecule and verbal memory was also confirmed at the protein level. By using ONCs from living subjects, we now provide more specific information regarding molecular expression and clinical phenotypes. The use of ONCs also provides the opportunity of validating the relationship not only at the RNA level but also protein level, leading to the potential of functional assays in the future. Taken together, we now provide evidence that supports the utility of ONCs as a tool for the "druggable genome" approach in translational psychiatry.
author2 Lee Kong Chian School of Medicine (LKCMedicine)
author_facet Lee Kong Chian School of Medicine (LKCMedicine)
Mihaljevic, Marina
Lam, Max
Ayala-Grosso, Carlos
Davis-Batt, Finn
Schretlen, David J.
Ishizuka, Koko
Yang, Kun
Sawa, Akira
format Article
author Mihaljevic, Marina
Lam, Max
Ayala-Grosso, Carlos
Davis-Batt, Finn
Schretlen, David J.
Ishizuka, Koko
Yang, Kun
Sawa, Akira
author_sort Mihaljevic, Marina
title Olfactory neuronal cells as a promising tool to realize the "druggable genome" approach for drug discovery in neuropsychiatric disorders
title_short Olfactory neuronal cells as a promising tool to realize the "druggable genome" approach for drug discovery in neuropsychiatric disorders
title_full Olfactory neuronal cells as a promising tool to realize the "druggable genome" approach for drug discovery in neuropsychiatric disorders
title_fullStr Olfactory neuronal cells as a promising tool to realize the "druggable genome" approach for drug discovery in neuropsychiatric disorders
title_full_unstemmed Olfactory neuronal cells as a promising tool to realize the "druggable genome" approach for drug discovery in neuropsychiatric disorders
title_sort olfactory neuronal cells as a promising tool to realize the "druggable genome" approach for drug discovery in neuropsychiatric disorders
publishDate 2023
url https://hdl.handle.net/10356/169592
_version_ 1773551327059640320